Sort
59,101 grants matching “hypertension”
Research Infrastructure in Minority Institutions (RIMI) at Tougaloo College
$751,392Beverly Wade Hogan · Tougaloo College · P20 · FY2009 · MD
Optimal physical activity timing and 24-hour activity composition for prevention of hypertensive disorders of pregnancy
$751,124Sylvia E Badon · Kaiser Foundation Research Institute · R01 · FY2025 · HL
Epidemiologic Determinants of Change in Cardiac Structure and Function (ECHO-SOL 2)
$750,923Carlos Jose Rodriguez · Wake Forest University Health Sciences · R01 · FY2017 · HL
Genetic and Stem Cell Model of Cardiac Metabolic Disease
$750,912Joseph C Wu · Stanford University · R01 · FY2020 · HL
Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy
$750,797Aaron K Olson · Seattle Children'S Hospital · R01 · FY2023 · HL
Ethnicity and fat deposition in obesity-related disease in youth
$750,768Vicente Gilsanze · University Of Southern California · P60 · FY2010 · MD
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
$750,752Abraham Reichenberg · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HD
Changing the Default for Tobacco Treatment
$750,747Kimber P Richter · University Of Kansas Medical Center · R01 · FY2017 · HL
Molecular Mechanisms of 20-HETE-mediated Vascular Dysfunction and Hypertension
$750,714Michal Laniado Schwartzman · New York Medical College · R01 · FY2019 · HL
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
$750,608Peter J Leary · University Of Washington · R33 · FY2025 · HL
AT1 Receptor Control in Chronic Hypertension Attenuation
$750,536Mohan K. Raizada · University Of Florida · R01 · FY2007 · HL
PAR2 Pepducins as a Novel Treatment of Idiopathic Pulmonary Fibrosis
$750,502Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2019 · HL
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
$750,496James A. Blumenthal · Duke University · R01 · FY2010 · HL
Receptor Specific Mechanisms of Endothelin Control of the Renal Microcirculation
$750,488Edward W. Inscho · Augusta University · P01 · FY2013 · HL
Randomized Trial of a Healthy Weight Intervention for Youth with Serious Emotional Disturbance
$750,450Gail L Daumit · Johns Hopkins University · R01 · FY2017 · MH
Sparking Advancements in Genomic Medicine
$750,442Larisa Humma Cavallari · University Of Florida · U01 · FY2022 · HG
Atheroprotection by smooth muscle selective RhoGAPs
$750,361Joan M. Taylor · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
$750,350Tamer S Ibrahim · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Determinants and Cardiovascular Consequences of Disparities in Sleep and Circadian Rhythms between Black and White Adults
$750,342Mercedes Renee Carnethon · Northwestern University At Chicago · R01 · FY2023 · HL
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure)
$750,332John A Dodson · New York University School Of Medicine · R01 · FY2022 · HL
Hypertension Telemanagement in African Americans
$750,308Joseph E Finkelstein · University Of Maryland Baltimore · R01 · FY2007 · HL
Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus
$750,260Matthew A Allison · University Of California, San Diego · R01 · FY2021 · HL
PROTECT: optima4BP 2.0: prediction of Optimal Treatment and Route to achieve and maintain BP Target
$750,249Gabriela Voskerician · Optima Integrated Health, Inc. · R44 · FY2020 · HL
A Hybrid Type 1 Effectiveness-Implementation Study of Social Incentives Strategies to Increase Physical Activity
$750,189Karen Glanz · University Of Pennsylvania · R01 · FY2023 · HL
Endothelin-dependent NOS activation in the kidney
$750,106Jennifer S Pollock · Augusta University · P01 · FY2011 · HL